期刊文献+

高糖对小鼠足细胞表型转化的诱导作用及机制探讨 被引量:2

Exploration on the mechanism of high glucose-induced epithelial-mesenchymal transition in podocytes
下载PDF
导出
摘要 目的观察高糖对小鼠足细胞表型转化的诱导作用,并探讨其机制。方法将传代培养后的小鼠足细胞随机分为A、B、C三组,A组常规培养,B组加入终浓度为30 mmol/L的葡萄糖、C组加入终浓度为30 mmol/L的葡萄糖及10μmol/L的蛋白质酪氨酸激酶(JAK2)特异性阻断剂α-氰-(3,4-二羟基)-N-苄基肉桂酰胺(AG490)进行培养,48 h后收集细胞,采用Western blot法检测足细胞中自身标志物人肾病蛋白(Nephrin)、间充质细胞标志物α-平滑肌肌动蛋白(α-SMA)及磷酸化蛋白质酪氨酸激酶(p-JAK2)蛋白,采用RT-PCR检测足细胞中的Nephrin、α-SMA mRNA。结果 A组足细胞中Nephrin、α-SMA、p-JAK2蛋白积分光密度值分别为0.96±0.01、0.21±0.02、0.39±0.01,B组分别为0.58±0.01、0.66±0.07、0.71±0.02,C组分别为0.87±0.04、0.35±0.02、0.41±0.04;A组足细胞中Nephrin、α-SMA mRNA的相对表达量为1.53±0.04、0.57±0.01,B组分别为0.82±0.09、0.89±0.03,C组分别为1.30±0.04、0.78±0.03。B组与A组比较,P均<0.05;C组与B组比较,P均<0.05。结论高糖可通过激活JAK/STAT信号途径诱导足细胞发生表型转化。 Objective To investigate the mechanism of high glucose-induced epithelial-mesenchymal transition in podocytes. Methods Cultured mouse podocytes were divided into three groups: group A (cells cultured conventionally), group B (cells cultured in 30 mmol/L glucose condition) and group C (3 cells cultured in 30 mmoL/L glucose and 10μmol/L AG490 conditions). Cells were collected after cultured 48 h. Western blotting analysis was used to determine the expression of nephrin, α-SMA and p-JAK2. RT-PCR analysis was used to detect the nephrin and α-SMA mRNA. Results The relative absorbance values of nephrin, α-SMA and p-JAK2 were 0.96 ±0.01,0.21±0. 02,0.39 ±0. 01 in group A, 0.58 ±0.01,0.66 ±0.07,0.71±0.02 in groupB, 0. 87 ± 0. 04 ,0. 35±0. 02 ,0. 41±0. 04 in group C. The relativeab-sorbance values of nephrin,α-SMA mRNA were 1.53 ±0.04,0.57 ±0.01 in group A,0.82 ±0.09,0.89 ±0.03 in group B, 1.30±0. 04,0.78 ±0.03 in group C. Compared with group B, these values in group A and C showed significant difference (all P 〈 0.05 ). Conclusion High glucose can induce the epithelial-mesenchymal transition in podocytes by activation of the JAK/STAT pathway.
出处 《山东医药》 CAS 2012年第34期22-24,共3页 Shandong Medical Journal
基金 河北省教育厅科学研究项目(2011168) 河北省卫生厅医学科学研究重点课题资项目(20110081)
关键词 高糖状态 足细胞 上皮细胞-间充质细胞表型转化 人肾病蛋白 Α-平滑肌肌动蛋白 蛋白质酪氨酸激酶 信号通路 high glucose condition podocyte epithelial-mesenchymal transition nephrin α smooth mascle actin protein tyrosine kinase signaling pathway
  • 相关文献

参考文献12

  • 1Li JJ, Kwak S J, Jung DS, et al. Podocyte biology in diabetic nephropathy [ J ]. Kidney Int, 2007,106 (Suppl) :36 -42.
  • 2Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy [ J ]. Curr Diabetes Rev, 2008, 4(1) :39-45.
  • 3Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy [ J ]. Nephron Physiol, 2007,106 (2) :26-31.
  • 4Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint[J]. Kidney Int, 2008,74 ( 1 ) :22-36.
  • 5Li Y, Kang YS, Dai C, et al. Epethelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria[J]. Am J Pathol, 2008,172(2) :299-308.
  • 6Yamaquchi Y, Iwano M, Suzuki D, et al. Epethelial mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy[J]. Am J Kidney Dis, 2009,54(4):653-664.
  • 7Wang C, Liu X, Ke Z, et al. Mesangial medium from IgA Nephropathy patients induces podocyte epithelial-to-mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/ Akt signaling pathway[J]. Cell Physiol Biochem, 2012,29 ( 5-6 ) : 743-752.
  • 8Dai HY, Zheng M, Lv LL, et al. The roles of connective tissue growth factor and integrin-linded kinase in high glucose-induced phenotypic alterations of podocytes[J]. J Cell Biochem, 2012,113 ( 1 ) :293-301.
  • 9Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis[J]. J Am Soc Nephrol, 2010,21(2) :212-222.
  • 10Zhang Z, Sun L, Wang Y, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy[ J ]. Kidney Int, 2008,73 (2) :163-171.

二级参考文献9

  • 1刘辉,姚咏明.细胞内炎症信号通路交汇作用研究进展[J].中国病理生理杂志,2005,21(8):1607-1613. 被引量:49
  • 2Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? [J]. Kidney Int, 1999,56 (5) : 1627 - 1637.
  • 3Ziyadeh FN. Significance of tubulointerstitial changes in diabetic renal disease [ J ]. Kidney Int, 1996,54 ( 5 ) : S10 -S13.
  • 4Marrero MB, Banes- Berceli AK, Stern DM, et al. Role of the JAK/STAT signaling pathway in diabetic nephropathy[J]. Am J Physiol, 2006,290(4) :F762 - F768.
  • 5Amiri F, Shaw S, Wang X, et al. Angiotensin Ⅱ activation of the JAK/STAT pathway in mesangial cells is altered by high glucose[J]. Kidney Int, 2002,61 (5) : 1605 - 1616.
  • 6Levy DE, Darnell JE. STATs: transcriptional control and biological impact [ J ]. Nat Rev Mol Cell Biol, 2002,3 (9) :651 -662.
  • 7Huang JS, Guh JY, Hung WC, et al. Role of the Janus (JAK)/signal transducers and activators of transcription (STAT) cascade in advanced glycation end - product - induced cellular mitogenesis in NRK - 49F cells [ J ]. Biochem J,1999,342( Pt 1 ) :231 -238.
  • 8Banes AK,Shaw S,Jenkins J, et al. Angiotensin Ⅱ blockade prevents hyperglycemia - induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli [ J ]. Am J Physiol Renal Physiol,2004,286(4) : 653-659.
  • 9范贤明,李振华,侯显明,于润江.博莱霉素致大鼠肺纤维化过程中肺泡巨噬细胞STAT_1的活化和蛋白表达的研究[J].中华结核和呼吸杂志,2002,25(1):57-58. 被引量:13

共引文献14

同被引文献22

  • 1魏爱英,马春燕,牟文丽.多烯紫杉醇抑制乳腺肿瘤细胞增殖及诱导凋亡的实验研究[J].山东医药,2005,45(8):22-23. 被引量:7
  • 2Tannock IF,de Wit R,Berry WR. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer[J].{H}New England Journal of Medicine,2004,(15):1502-1512.
  • 3Petrylak DP,Tangen CM,Hussain MH. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer[J].{H}New England Journal of Medicine,2004,(15):1513-1520.
  • 4Symmans WF,Volm MD,Shapiro RL. Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration:implications for early prediction of breast cancer response to neoadjuvant treatment[J].{H}Clinical Cancer Research,2000,(12):4610-4617.
  • 5Duronio V,Scheid MP,Ettinger S. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity[J].{H}CELLULAR SIGNALLING,1998,(4):233-239.
  • 6Lee SO,Lou W,Qureshi KM. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer ceils[J].{H}PROSTATE,2004,(4):303-309.
  • 7Miyamoto N,Sugita K,Goi K. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 1 1q23 translocation or Philadelphia chromosome[J].{H}LEUKEMIA,2001,(11):1758-1768.
  • 8Catz SD,Johnson JL. BCL-2 in prostate cancer:a minireview[J].{H}APOPTOSIS,2003,(1):29-37.
  • 9Dingemans AM,witlox MA,Stallaert RA. Expression of DNA topoisomerase llalpha and topoisomerase llbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer[J].{H}Clinical Cancer Research,1999,(8):2048-2058.
  • 10Buettner R,Mora LB,Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention[J].{H}Clinical Cancer Research,2002,(4):945-954.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部